SIGILON THERAPEUTICS INC (SGTX)
US82657L2060 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 107.14M | 202.23M | 76.07M | |||
| Cash Equivalents | 41.26M | 42.07M | N/A | N/A | N/A | |||
| Marketable Securities | 15.11M | 27.56M | 16.21M | N/A | N/A | |||
| Receivables | 4.96M | 3.46M | 59.00K | 177.00K | 140.00K | |||
| Other Current Assets | 3.32M | 1.33M | 2.98M | 1.80M | 730.00K | |||
| Total Current Assets | 64.65M | 74.41M | 126.39M | 204.21M | 76.94M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.90M | 11.83M | 16.86M | 19.72M | 12.80M | |||
| Other Non-Current Assets | 1.04M | 1.03M | 1.12M | 1.12M | 640.00K | |||
| Total Non-Current Assets | 11.94M | 12.87M | 17.98M | 20.84M | 13.44M | |||
| TOTAL ASSETS | 76.59M | 87.28M | 144.37M | 225.05M | 90.38M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 6.67M | 6.67M | 1.67M | N/A | N/A | |||
| Accrued Expenses | 7.96M | 10.26M | 13.63M | 13.01M | 9.08M | |||
| Accounts Payable | 1.33M | 936.00K | 2.34M | 1.99M | 2.01M | |||
| Other Current Liabilities | 13.03M | 13.13M | 17.25M | 32.02M | 29.29M | |||
| Total Current Liabilities | 28.99M | 30.99M | 34.89M | 47.02M | 40.38M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.41M | 12.02M | 18.41M | 19.81M | 15.20M | |||
| Other Non-Current Liabilities | 3.89M | 5.12M | 13.91M | 12.07M | 22.36M | |||
| Total Non-Current Liabilities | 14.30M | 17.14M | 32.32M | 31.88M | 37.55M | |||
| TOTAL LIABILITIES | 43.29M | 48.14M | 67.21M | 78.89M | 77.93M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -264.18M | -256.80M | -213.24M | -135.93M | -81.32M | |||
| Additional Paid In Capital | 297.71M | 296.34M | 290.38M | 282.05M | 3.55M | |||
| Common Shares | 32.00K | 32.00K | 32.00K | 31.00K | 90.22M | |||
| Other Shareholders' Equity | -273.00K | -429.00K | -10.00K | N/A | N/A | |||
| Shares Outstanding | 2.50M | 32.47M | 2.49M | 2.42M | 28.79M | |||
| Tangible Book Value per Share | 13.31 | 1.21 | 31.00 | 60.39 | -2.70 | |||
| Total Shareholders' Equity | 33.29M | 39.14M | 77.16M | 146.16M | 12.44M | |||
| TOTAL LIABILITIES AND EQUITY | 76.59M | 87.28M | 144.37M | 225.05M | 90.38M | |||
| Statistics | ||||||||
| Debt/Equity | 0.31 | 0.31 | 0.24 | 0.14 | 1.22 | |||
| Current Ratio | 2.23 | 2.40 | 3.62 | 4.34 | 1.91 | |||
| Return On Assets (ROA) | -48.41% | -49.91% | -53.55% | -24.26% | -48.61% | |||
| Return On Equity (ROE) | -111.37% | -111.29% | -100.20% | -37.36% | -353.14% | |||
All data in USD